Forian Inc
FORA
View Detailed Chart
2.310USD
0.000
Close 09/19, 16:00（ET）Quotes delayed by 15 min
72.08MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
+2.67%
1 Month
+21.58%
6 Months
+11.06%
Year to Date
+12.14%
1 Year
+2.67%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated: 2025-09-19Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Buy
Current Rating
5.000
Target Price
+116.45%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Forian Inc. is a technology solutions company. The Company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. Its operations consist of providing analytic and information services to the healthcare and related industries, which are all subscription and services-based solutions. Its offerings include commercial, Real World Evidence (RWE) and market access solutions and data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company provides its information solutions both as an enabling technology to consultants and service providers serving the healthcare and life sciences industries, as well as to end users in the healthcare and life sciences industries. It also offers machine learning applications for the financial services community.
Growing
The company is in a growing phase, with the latest annual income totaling USD 20.15M.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD 3.77M.%!(EXTRA int=2)
Undervalued
The company’s latest PE is -79.68, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 21.65M shares, increasing 6.45% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 775.14K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.36.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Forian Inc. is a technology solutions company. The Company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. Its operations consist of providing analytic and information services to the healthcare and related industries, which are all subscription and services-based solutions. Its offerings include commercial, Real World Evidence (RWE) and market access solutions and data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company provides its information solutions both as an enabling technology to consultants and service providers serving the healthcare and life sciences industries, as well as to end users in the healthcare and life sciences industries. It also offers machine learning applications for the financial services community.
Ticker SymbolFORA
CompanyForian Inc
CEOMr. Max Wygod
Websitehttps://forian.com/
Related Instruments
+1.86%
+4.06%
+3.06%
-1.05%
+4.52%
+1.41%
-0.42%
+1.22%
+1.15%
+2.32%
-1.25%
-0.27%
+3.21%
-0.11%
+3.98%
+0.05%
-0.86%
+1.47%
+1.09%
+0.44%
